Notice2022-03098
Brian Michael Parks: Final Debarment Order
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 14, 2022
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Brian Michael Parks for a period of 5 years from importing or offering for import any article of food (including dietary supplements) or drug into the United States. FDA bases this order on a finding that Mr. Parks was convicted of one felony count under Federal law for distribution of an unapproved new drug with the intent to defraud and mislead. The factual basis supporting Mr. Parks' conviction, as described below, is conduct relating to the importation into the United States of any food and of any drug or controlled substance. Mr. Parks was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of November 17, 2021 (30 days after receipt of the notice), Mr. Parks had not responded. Mr. Parks' failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 30 (Monday, February 14, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 30 (Monday, February 14, 2022)]
[Notices]
[Pages 8264-8265]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-03098]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2021-N-0304]
Brian Michael Parks: Final Debarment Order
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is issuing an order
under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring
Brian Michael Parks for a period of 5 years from importing or offering
for import any article of food (including dietary supplements) or drug
into the United States. FDA bases this order on a finding that Mr.
Parks was convicted of one felony count under Federal law for
distribution of an unapproved new drug with the intent to defraud and
mislead. The factual basis supporting Mr. Parks' conviction, as
described below, is conduct relating to the importation into the United
States of any food and of any drug or controlled substance. Mr. Parks
was given notice of the proposed debarment and was given an opportunity
to request a hearing to show why he should not be debarred. As of
November 17, 2021 (30 days after receipt of the notice), Mr. Parks had
not responded. Mr. Parks' failure to respond and request a hearing
constitutes a waiver of his right to a hearing concerning this matter.
DATES: This order is applicable February 14, 2022.
ADDRESSES: Submit applications for termination of debarment to the
Dockets Management Staff, Food and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852, 240-402-7500, or at <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
FOR FURTHER INFORMATION CONTACT: Jaime Espinosa, Division of
Enforcement (ELEM-4029), Office of Strategic Planning and Operational
Policy, Office of Regulatory Affairs, Food and Drug Administration,
12420 Parklawn Dr., Rockville, MD 20857, 240-402-8743, or at
<a href="/cdn-cgi/l/email-protection#2347464142514e464d5750634547420d4b4b500d444c55"><span class="__cf_email__" data-cfemail="1a7e7f787b68777f746e695a7c7e7b34727269347d756c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
I. Background
Section 306(b)(1)(C) of the FD&C Act (21 U.S.C. 335a(b)(1)(C))
permits FDA to debar an individual from importing an article of food or
offering such an article for import into the United States if FDA
finds, as required by section 306(b)(3)(A) of the FD&C Act, that the
individual has been convicted of a felony for conduct relating to the
importation into the United States of any food. Section 306(b)(1)(D) of
the FD&C Act permits debarment of an individual from importing or
offering for import any drug into the United States if the FDA finds,
as required by section 306(b)(3)(C) of the FD&C Act that the individual
has been convicted of a felony for conduct relating to the importation
into the United States of any drug or controlled substance.
On February 16, 2021, Mr. Parks was convicted, as defined in
section 306(l)(1) of the FD&C Act in the U.S. District Court for the
Western District of Virginia, after his plea of guilty, when the court
entered judgment against him for the offense of distribution of an
unapproved new drug with the intent to defraud and mislead, in
violation of sections 301(d) and 303(a)(2) of the FD&C Act 21 U.S.C.
331(d) and 333(a)(2). The FDA's finding that debarment is appropriate
is based on the felony conviction referenced herein. The factual basis
for this conviction is as follows:
As contained in the information in Mr. Parks' case, filed on
November 23, 2020, he was the owner and operator of MedFitRX Inc.,
later known as MedFit Sarmacuticals Inc. (collectively referred to as
MedFitRX herein), a purported sport supplement company based in North
Carolina. MedFitRX imported Selective Androgen Receptor Modulators
(SARMs) in order to use them in MedFitRx products. SARMs are synthetic
chemicals designed to mimic the effects of testosterone and other
anabolic steroids. From approximately March 2016 to September 2019, Mr.
Parks imported SARMs and other drug active ingredients from China on
multiple occasions. The drug active ingredients he imported included
MK-677, S-4, MK-2866, GW-501516, LGD-4033, and RAD140, among others. In
addition, on or about May 17, 2018, Mr. Parks sold two MedFitRX
products to undercover FDA Office of Criminal Investigation agents
posing as consumers. The first product Mr. Parks sold to these
undercover agents, Lucky SARMS Magical AF, contained the drugs S-23 and
SR9009, which he had caused to be imported into the United States. The
second product, Estrovert,
[[Page 8265]]
contained the anabolic steroid Methyldienolone, a controlled substance
prohibited under the Designer Steroid Act, 21 U.S.C. 802(41), which Mr.
Parks also caused to be imported into the United States. Mr. Parks
worked with others to conceal the importation of these and other
unapproved drugs as they were disguised and misdeclared as articles of
food, specifically ``biscuit mix powder,'' ``corn powder,'' ``grain mix
powder,'' ``bread mix powder,'' and ``milk tea powder.'' Mr. Parks then
included these drug active ingredients in MedFitRX products, which were
unapproved drugs that he introduced and delivered for introduction into
interstate commerce. Mr. Parks knowingly marketed these MedFitRX
products as ``dietary supplements'' and ``sports supplements'' to
create the impression they were safe and legal to use, and otherwise
intentionally failed to include certain drug active ingredients on the
product labels.
As a result of this conviction, FDA sent Mr. Parks, by certified
mail, on October 12, 2021, a notice proposing to debar him for a 5-year
period from importing or offering for import any article of food or
drug into the United States. The proposal was based on a finding under
section 306(b)(1)(C) and (b)(3)(C) of the FD&C Act that Mr. Parks'
felony conviction of distribution of an unapproved new drug with the
intent to defraud and mislead constitutes conduct relating to the
importation into the United States of an article of food and any drug
or controlled substance because Mr. Parks illegally imported unapproved
drugs into the United States, working with others to disguise and
misdeclare them as articles of food, and then distributed those
unapproved drugs to consumers in the United States, marketing them as
``dietary supplements'' and ``sports supplements.'' In proposing a
debarment period, FDA weighed the considerations set forth in section
306(c)(3) of the FD&C Act that it considered applicable to Mr. Parks'
offense, and concluded that the felony offense warranted the imposition
of a 5-year period of debarment.
The proposal informed Mr. Parks of the proposed debarment and
offered him an opportunity to request a hearing, providing him 30 days
from the date of receipt of the letter in which to file the request,
and advised him that failure to request a hearing constituted a waiver
of the opportunity for a hearing and of any contentions concerning this
action. Mr. Parks received the proposal and notice of opportunity for a
hearing on October 18, 2021. Mr. Parks failed to request a hearing
within the timeframe prescribed by regulation and has, therefore,
waived his opportunity for a hearing and waived any contentions
concerning his debarment (21 CFR part 12).
II. Findings and Order
Therefore, the Assistant Commissioner, Office of Human and Animal
Food Operations, under section 306(b)(1)(C) and (b)(3)(C) of the FD&C
Act, under authority delegated to the Assistant Commissioner, finds
that Mr. Brian Michael Parks has been convicted of a felony under
Federal law for conduct relating to the importation into the United
States of an article of food and of a drug or controlled substance, and
that he is subject to a 5-year period of debarment.
As a result of the foregoing finding, Mr. Parks is debarred for a
period of 5 years from importing or offering for import articles of
food or any drug or controlled substances into the United States,
applicable (see DATES). Pursuant to section 301(cc) of the FD&C Act,
the importing or offering for import into the United States of an
article of food or of any drug or controlled substance by, with the
assistance of, or at the direction of Mr. Parks is a prohibited act.
Any application by Mr. Parks for termination of debarment under
section 306(d)(1) of the FD&C Act should be identified with Docket No.
FDA-2021-N-0304 and sent to the Dockets Management Staff (see
ADDRESSES). The public availability of information in these submissions
is governed by 21 CFR 10.20.
Publicly available submissions will be placed in the docket and
will be viewable at <a href="https://www.regulations.gov">https://www.regulations.gov</a> or at the Dockets
Management Staff (see ADDRESSES) between 9 a.m. and 4 p.m., Monday
through Friday, 240-402-7500.
Dated: February 8, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-03098 Filed 2-11-22; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 14, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.